https://www.massgeneral.org/neurology/als/news/healeyamg-announces-platform-trial-update-fosigotifator
Sean M. Healey & AMG Center Announces Update in ALS Platform Trial with Fosigotifator
https://www.calicolabs.com/press/calico-life-sciences-announces-fosigotifator-granted-breakthrough-therapy-designation-by-the-u-s-fda-for-the-treatment-of-vanishing-white-matter-disease/
Calico Life Sciences Announces Fosigotifator Granted Breakthrough Therapy Designation by the U.S....
Jun 23, 2026 - South San Francisco, Calif., June 23, 2026 – Calico Life Sciences LLC (Calico), a clinical-stage biotechnology organization focused on aging and age-related...
calico life sciences